Somatostatin analogues, a series of tissue transglutaminase inducers, as a new tool for therapy of mesenchimal tumors of the gastrointestinal tract

Amino Acids

Volumn 32, Issue 3, 2007, Pages 395-400

  Palmieri, G ^a   Montella, L ^a   Aiello, C ^b   Barbieri, F ^c   Di Vizio, D ^a   Schulz, S ^d   Beninati, S ^e   Budillon, A ^f   Caraglia, M ^f   Insabato, L ^a   Florio, T ^c  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d OTTO VON GUERICKE UNIVERSITY   (Germany)

^e UNIVERSITY OF ROME TOR VERGATA   (Italy)

^f NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Gastrointestinal leiomyosarcomas; GIST; Imatinib; Immunohistochemistry; Somatostatin receptor; Tissue transglutaminase

Indexed keywords

IMATINIB; POLYCLONAL ANTIBODY; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; RECEPTOR SUBTYPE; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR 1; SOMATOSTATIN RECEPTOR 2; SOMATOSTATIN RECEPTOR 3; SOMATOSTATIN RECEPTOR 4; SOMATOSTATIN RECEPTOR 5;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG TARGETING; FEMALE; GASTROINTESTINAL TUMOR; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEIOMYOMA; LEIOMYOSARCOMA; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RECEPTOR INTRINSIC ACTIVITY; TISSUE SECTION;

ADULT; AGED; DRUG RESISTANCE, NEOPLASM; ENZYME ACTIVATION; ENZYME INDUCTION; FEMALE; GASTROINTESTINAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEIOMYOMA; LEIOMYOSARCOMA; MALE; MESODERM; MIDDLE AGED; PIPERAZINES; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-KIT; PYRIMIDINES; RECEPTORS, SOMATOSTATIN; SOMATOSTATIN; TRANSGLUTAMINASES;

EID: 34147138843     PISSN: 09394451     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00726-006-0386-y     Document Type: Article

References (29)

1. A Albini T Florio D Giunciuglio L Masiello S Carlone A Corsaro S Thellung T Cai DM Noonan G Schettini 1999 Somatostatin controls Kaposi's sarcoma tumor growth through inhibition of angiogenesis FASEB J 13 647 655
2. L Buscail N Delesque J-P Esttve N Saint-Laurent H Pratst P Clerc P Robberechti GI Bell C Liebow AV Schallyii N Vaysse C Susini 1994 Stimulation of tyrosine phosphatase and inhibition of cell proliferation by somatostatin analogues: mediation by human somatostatin receptor subtypes SSTR1 and SSTR2 Proc Natl Acad Sci USA 91 2315 2319
3. CM de Silva R Reid 2003 Gastrointestinal stromal tumors (GIST): c-kit mutations, CD117 expression, differential diagnosis and targeted therapy with imatinib Pathol Oncol Res 9 13 19
4. T Florio G Schettini 1996a Multiple intracellular effectors modulate physiological functions of the cloned somatostatin receptors J Mol Endocrinol 17 89 100
5. T Florio A Scorizello M Fattore V D'Alto S Salzano G Rossi MT Berlingieri A Fusco G Schettini 1996b Somatostatin inhibits PC Cl3 thyroid cell proliferation through the modulation of phosphotyrosine activity. Impairment of the somatostatinergic effects by stable expression of E1A viral oncogene J Biol Chem 271 6129 6136
6. T Florio S Arena S Thellung R Iuliano A Corsaro A Massa A Pattarozzi A Bajetto F Trapasso A Fusco G Schettini 2001 The activation of the phosphotyrosine phosphatase η (r-PTPη) is responsible for the somatostatin inhibition of PC Cl3 thyroid cell proliferation Mol Endocrinol 15 1838 1852
7. T Florio M Morini V Villa S Arena A Corsaro S Thellung MD Culler U Pfeffer DM Noonan G Schettini A Albini 2003a Somatostatin inhibits tumor angiogenesis and growth via somatostatin receptor-3-mediated regulation of endothelial nitric oxide synthase and mitogen-activated protein kinase activities Endocrinology 144 1574 1584
8. T Florio L Montella A Corsaro A De Chiara G Apice F Fazioli S Lastoria G Schettini G Palmieri 2003b In vitro and in vivo expression of somatostatin receptors in intermediate and malignant soft tissue tumors Anticancer Res 23 2465 2471
9. M Gugger B Waser A Kappeler A Schonbrunn JC Reubi 2004 Cellular detection of sst2A receptors in human gastrointestinal tissue Gut 53 1431 1436
10. MC Heinrich CL Corless A Duensing L McGreevey CJ Chen N Joseph S Singer DJ Griffith A Haley A Town GD Demetri CD Fletcher JA Fletcher 2003 PDGFRA activating mutations in gastrointestinal stromal tumors Science 299 708 710
11. S Hirota K Isozaki Y Moriyama K Hashimoto T Nishida S Ishiguro K Kawano M Hanada A Kurata M Takeda G Muhammad Tunio Y Matsuzawa Y Kanakura Y Shinomura Y Kitamura 1998 Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors Science 279 577 580
12. H Joensuu PJ Roberts M Sarlomo-Rikala LC Andersson P Tervahartiala D Tuveson S Silberman R Capdeville S Dimitrijevic B Druker GD Demetri 2001 Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor N Engl J Med 344 1052 1056
13. JS Koh J Trent L Chen A El-Naggar K Hunt R Pollock W Zhang 2004 Gastrointestinal stromal tumors: overview of pathological features, molecular biology, and therapy with imatinib mesylate Histol Histopathol 19 565 574
14. SW Lamberts AJ van der Lely WW de Herder LJ Hofland 1996 Octreotide N Engl J Med 334 246 254
15. J Lasota A Dansonka-Mieszkowska T Stachura R Schneider-Stock M Kallajoki SE Steigen M Sarlomo-Rikala C Boltze R Kordek A Roessner J Stachura M Miettinen 2003 Gastrointestinal stromal tumors with internal tandem duplications in 3′ end of KIT juxtamembrane domain occur predominantly in stomach and generally seem to have a favourable course Mod Pathol 16 1257 1264
16. A Massa F Barbieri C Aiello R Iuliano S Arena A Pattarozzi A Corsaro V Villa A Fusco G Zona R Spaziante G Schettini T Florio 2004a The phosphotyrosine phosphatase PTPη mediates somatostatin inhibition of glioma proliferation via the dephosphorylation of ERK1/2 Ann NY Acad Sci 1030 264 273
17. A Massa F Barbieri C Aiello S Arena A Pattarozzi P Pirani A Corsaro R Iuliano A Fusco G Zona R Spaziante T Florio G Schettini 2004b The expression of the phosphotyrosine phosphatase DEP-1/PTPη dictates the responsivity of glioma cells to somatostatin inhibition of cell proliferation J Biol Chem 279 29004 29012
18. M Miettinen L Sobin J Lasota 2005 Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up Am J Surg Pathol 29 52 68
19. MG Pan T Florio P Stork 1992 G protein activation of a hormone-stimulated phosphatase in human tumor cells Science 256 1215 1217
20. JC Reubi JA Laissue 1995 Multiple actions of somatostatin in neoplastic disease Trends Pharm Sci 16 110 115
21. JC Reubi B Waser JA Laissue JO Gebbers 1996 Somatostatin and vasoactive intestinal peptide receptors in human mesenchymal tumors: in vitro identification Cancer Res 56 1922 1931
22. JC Reubi JA Laissue B Waser DL Steffen RW Hipkin A Schonbrunn 1999 Immunohistochemical detection of somatostatin sst2a receptors in the lymphatic, smooth muscular, and peripheral nervous system of the human gastrointestinal tract: facts and artifacts J Clin Endocrinol Metabol 84 2942 2950
23. AV Schally 1988 Oncological applications of somatostatin analogues Cancer Res 48 6977 6985
24. A Schonbrunn 1999 Somatostatin receptors present knowledge and future directions Ann Oncol 10 Suppl 2 17 21
25. S Schulz SU Pauli S Schulz M Handel K Dietzmann R Firsching V Hollt 2000 Immunohistochemical determination of five somatostatin receptors in meningioma reveals frequent overexpression of somatostatin receptor subtype sst2A Clin Cancer Res 6 1865 1874
26. B Szende AV Schally K Lapis 1991 Immunocytochemical demonstration of tissue transglutaminase indicative of programmed cell death (apoptosis) in hormone sensitive mammary tumours Acta Morphol Hung 39 53 58
27. RM Thomas LH Sobin 1995 Gastrointestinal cancer: incidence and prognosis by histologic type. SEER population-based data: 1973-1987 Cancer 75 154 170
28. AT van Oosterom I Judson J Verweij S Stroobants E Donato di Paola S Dimitrijevic M Martens A Webb R Sciot M Van Glabbeke S Silberman OS Nielsen European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group 2001 Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study Lancet 358 1421 1423
29. E Wandzioch CE Edling RH Palmer L Carlsson B Hallberg 2004 Activation of the MAP kinase pathway by c-Kit is PI-3 kinase dependent in hematopoietic progenitor/stem cell lines Blood 104 51 57